No significant changes were observed in ESRD or renal death (Marso et al., 2016a)
Every breakthrough begins with a question, followed by years of research, testing, collaboration, and refinement
When their reflection shows gauntness or sagging, the contrast can feel like betrayal
In a 52-week randomized, double-blind, placebo-controlled phase 2 trial involving 64 adults at high fracture risk (due to low BMD or recent fragility fractures), participants received once-weekly semaglutide (1.0 mg) or placebo
Until now, patients with cirrhosis caused by MASH have often been excluded from clinical trials and have had limited treatment options, making the findings particularly noteworthy